185 related articles for article (PubMed ID: 8033037)
1. Local immune response to tumor invasion in esophageal squamous cell carcinoma. The expression of human leukocyte antigen-DR and lymphocyte infiltration.
Sadanaga N; Kuwano H; Watanabe M; Maekawa S; Mori M; Sugimachi K
Cancer; 1994 Jul; 74(2):586-91. PubMed ID: 8033037
[TBL] [Abstract][Full Text] [Related]
2. HLA-DR antigen expression in squamous epithelial dysplasia and squamous cell carcinoma of the esophagus: an immunohistochemical study.
Sumiyoshi K; Kuwano H; Watanabe M; Kitamura M; Toh Y; Sugimachi K
Oncol Rep; 1999; 6(2):301-6. PubMed ID: 10022993
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of simultaneous infiltration of HLA-DR-positive dendritic cells and tumor infiltrating lymphocytes into human esophageal carcinoma.
Furihata M; Ohtsuki Y; Sonobe H; Araki K; Ogata T; Toki T; Ogoshi S; Tamiya T
Tohoku J Exp Med; 1993 Mar; 169(3):187-95. PubMed ID: 8248911
[TBL] [Abstract][Full Text] [Related]
4. Pathogenesis of esophageal squamous cell carcinoma with lymphoid stroma.
Kuwano H; Sumiyoshi K; Sonoda K; Kitamura K; Toh Y; Nakashima H; Sugimachi K
Hepatogastroenterology; 2001; 48(38):458-61. PubMed ID: 11379332
[TBL] [Abstract][Full Text] [Related]
5. Relationship between the expression of HLA-DR antigen and the effectiveness of preoperative hyperthermo-chemo-radiotherapy in oesophageal cancer.
Kuwano H; Saeki H; Kawaguchi H; Sonoda K; Kitamura K; Nakashima H; Toh Y; Sugimachi K
Int J Hyperthermia; 1998; 14(5):435-44. PubMed ID: 9789768
[TBL] [Abstract][Full Text] [Related]
6. Tumor-Infiltrating CD4+ Lymphocytes Predict a Favorable Survival in Patients with Operable Esophageal Squamous Cell Carcinoma.
Chen K; Zhu Z; Zhang N; Cheng G; Zhang F; Jin J; Wu J; Ying L; Mao W; Su D
Med Sci Monit; 2017 Sep; 23():4619-4632. PubMed ID: 28949934
[TBL] [Abstract][Full Text] [Related]
7. Association of CD8+ T cell infiltration in oesophageal carcinoma lesions with human leucocyte antigen (HLA) class I antigen expression and survival.
Tsuchikawa T; Ikeda H; Cho Y; Miyamoto M; Shichinohe T; Hirano S; Kondo S
Clin Exp Immunol; 2011 Apr; 164(1):50-6. PubMed ID: 21352198
[TBL] [Abstract][Full Text] [Related]
8. Methylation of the promoter of human leukocyte antigen class I in human esophageal squamous cell carcinoma and its histopathological characteristics.
Qifeng S; Bo C; Xingtao J; Chuanliang P; Xiaogang Z
J Thorac Cardiovasc Surg; 2011 Mar; 141(3):808-14. PubMed ID: 21335133
[TBL] [Abstract][Full Text] [Related]
9. [Expression of HLA-DR antigen on head and neck carcinomas--immunohistological study].
Samukawa T
Nihon Jibiinkoka Gakkai Kaiho; 1993 Jan; 96(1):88-97. PubMed ID: 8459313
[TBL] [Abstract][Full Text] [Related]
10. [Research into the human leucocyte antigen I deletion and local lymphocytes infiltration in laryngeal carcinoma].
Niu C; Liu X; Zhou W; Jing L; Du B
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2002 Jun; 37(3):215-8. PubMed ID: 12772327
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of tumor-infiltrating immune cells and PD-L1 expression in esophageal squamous cell carcinoma.
Jiang Y; Lo AWI; Wong A; Chen W; Wang Y; Lin L; Xu J
Oncotarget; 2017 May; 8(18):30175-30189. PubMed ID: 28404915
[TBL] [Abstract][Full Text] [Related]
12. HLA-DR antigen- and S-100 protein-positive dendritic cells in esophageal squamous cell carcinoma--their distribution in relation to prognosis.
Furihata M; Ohtsuki Y; Ido E; Iwata J; Sonobe H; Araki K; Ogoshi S; Ohmori K
Virchows Arch B Cell Pathol Incl Mol Pathol; 1992; 61(6):409-14. PubMed ID: 1349780
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of HLA class I antigen-processing machinery components in esophageal squamous cell carcinomas: association with disease progression.
Liu Q; Hao C; Su P; Shi J
Scand J Gastroenterol; 2009; 44(8):960-9. PubMed ID: 19492245
[TBL] [Abstract][Full Text] [Related]
14. Circulating CD14(+)HLA-DR(-/low) myeloid-derived suppressor cell is an indicator of poor prognosis in patients with ESCC.
Huang H; Zhang G; Li G; Ma H; Zhang X
Tumour Biol; 2015 Sep; 36(10):7987-96. PubMed ID: 25967454
[TBL] [Abstract][Full Text] [Related]
15. The Fas counterattack in vivo: apoptotic depletion of tumor-infiltrating lymphocytes associated with Fas ligand expression by human esophageal carcinoma.
Bennett MW; O'Connell J; O'Sullivan GC; Brady C; Roche D; Collins JK; Shanahan F
J Immunol; 1998 Jun; 160(11):5669-75. PubMed ID: 9605174
[TBL] [Abstract][Full Text] [Related]
16. The expression of HLA-DR antigen in cervical neoplasia.
Raju GC; Teh M; Wee A
Cancer Detect Prev; 1994; 18(5):367-73. PubMed ID: 7812983
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of the immunological phenomena and relationship with clinicopathological characteristics of the tumor--the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ lymphocytes in squamous cell laryngeal carcinoma. Part II.
Starska K; Głowacka E; Kulig A; Lewy-Trenda I; Bryś M; Lewkowicz P
Folia Histochem Cytobiol; 2011; 49(4):593-603. PubMed ID: 22252753
[TBL] [Abstract][Full Text] [Related]
18. Human leukocyte antigen G is associated with esophageal squamous cell carcinoma progression and poor prognosis.
Zheng J; Xu C; Chu D; Zhang X; Li J; Ji G; Hong L; Feng Q; Li X; Wu G; Du J; Zhao Q
Immunol Lett; 2014 Sep; 161(1):13-9. PubMed ID: 24768599
[TBL] [Abstract][Full Text] [Related]
19. Increased intraepithelial CD3+ T-lymphocytes and high PD-L1 expression on tumor cells are associated with a favorable prognosis in esophageal squamous cell carcinoma and allow prognostic immunogenic subgrouping.
Jesinghaus M; Steiger K; Slotta-Huspenina J; Drecoll E; Pfarr N; Meyer P; Konukiewitz B; Bettstetter M; Wieczorek K; Ott K; Feith M; Langer R; Weichert W; Specht K; Boxberg M
Oncotarget; 2017 Jul; 8(29):46756-46768. PubMed ID: 28657901
[TBL] [Abstract][Full Text] [Related]
20. Local immune response in serous papillary carcinoma of the endometrium.
Tamiolakis D; Venizelos J; Lambropoulou M; Nikolaidou S; Tsikouras P; Jivannakis T; Papadopoulos N
Histol Histopathol; 2005 Apr; 20(2):403-8. PubMed ID: 15736043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
